Advertisement

Topics

Companies Related to "Amgen gets rights Captisol formulation technology BiTE" [Most Relevant Company Matches] RSS

23:18 EST 24th November 2017 | BioPortfolio

Here are the most relevant search results for "Amgen gets rights Captisol formulation technology BiTE" found in our extensive corporate database of over 50,000 company records.

Showing "Amgen gets rights Captisol formulation technology BiTE" Companies 1–25 of 5,800+

Extremely Relevant

CyDex Pharmaceuticals Inc.

CyDex Pharmaceuticals, Inc. is a specialty pharmaceutical company developing products and licensing its Captisol® technology. Captisol is currently incorporated in five FDA approved medications and marketed by three of the company’s licensees: Pfizer, Bristol-Myers Squibb and Prism Pharmaceuticals. In addition, the company is supporting drug develo...


CyDex Pharmaceuticals, Inc.

CyDex Pharmaceuticals, Inc. is a specialty pharmaceutical company developing products and licensing its Captisol® technology. Captisol is currently incorporated in five FDA approved medications and marketed by three of the company’s licensees: Pfizer, Bristol-Myers Squibb and Prism Pharmaceuticals. In addition, the company is supporting drug...

Relevant

Amgen Inc.

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight agai...


Amgen, Inc.

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight agai...

Amgen

The Amgen Foundation (www.amgen.com/citizenship/overview.html) seeks to advance science education; improve patient access to quality care; and strengthen the communities where Amgen staff members live and work. Since 1991, the Foundation has made $140 million in grants to nonprofit organizations throughout the United States, Puerto Rico and Europe that impact society in inspiring and innovative wa...

Amgen AB

Amgen är ett världsledande bioteknologiskt läkemedelsföretag. Genom vetenskapliga upptäckter och innovationer har företaget under 25 års tid bidragit till att radikalt förbättra människors liv. Amgen är föregångare i utvecklingen av nya produkter baserade på rekombinant DNA-teknik och molekylärbiologi och stod för lanseringen av bioteknikindustrins första storsäljande läkemedel....

Amgen Inc

Amgen is a leading human therapeutics company in the biotechnology industry. For 25 years, the company has tapped the power of scientific discovery and innovation to dramatically improve people’s lives.Amgen pioneered the development of novel products based on advances in recombinant DNA and molecular biology and launched the biotechnology industry’s first blockbuster medicines. Today, as a Fo...

Merck and Cardiome Pharma Corp.

In April 2009, Cardiome and Merck announced a collaboration and license agreement for the development and commercialization of vernakalant. The agreement provides Merck, Sharp and Dohme Corp. (formerly known as Merck & Co., Inc.) with exclusive global rights to vernakalant oral formulation for the maintenance of normal heart rhythm in patients with AF, and...

Micromet, Inc.

Micromet, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibody-based therapies for the treatment of cancer. Its product development pipeline includes novel antibodies generated with its proprietary BiTE® technology, as well as conventional monoclonal antibodies. Two of Micromet's BiTE antibodies and three of its conventional antibo...

Amgen Incorporated

Over the past quarter century, Amgen has pioneered the methods by which human proteins that play a role in disease processes are identified, isolated, produced in quantity and used as therapeutics. Today, Amgenhas research programs in inflammation, metabolic disorders and osteoporosis, neurology, oncology and hematology. The company has R&D facilities in Thousand Oaks, CA; San Francisco, CA; Cambr...

Frog Bite Productions

Otonomy, Inc.

Otonomy is a clinical stage biopharmaceutical company developing novel drug therapies for disorders of the inner and middle ear. The company's core technology is a sustained release formulation developed for optimal delivery of drugs from a single intratympanic (IT) injection. Broad applicability of this delivery and formulation technology has already been established across a number of therapeuti...

Anthera Pharmaceuticals Inc.

Anthera Pharmaceuticals is a privately-held company committed to developing and commercializing clinical pharmaceutical products that address unmet medical needs of patients with life-threatening, chronic and acute inflammatory diseases and autoimmune disorders. The Company has acquired from Eli Lilly and Company and Shionogi & Co.‚ Ltd. worldwide rights (excluding Japan) to a series of clin...

Unigene Laboratories, Inc.

Unigene Laboratories, Inc. is a biopharmaceutical company focusing on the oral and nasal delivery of large-market peptide drugs. Due to the size of the worldwide osteoporosis market, Unigene is targeting its initial efforts on developing calcitonin and PTH-based therapies. Fortical®, Unigene's nasal calcitonin product for the treatment of postmenopausal...

Bryn Aarflot AS (BAA)

Bryn Aarflot AS (BAA) is a privately owned consulting firm, providing assistance to inventors, companies and other intellectual property right owners within all areas of intellectual property law.BAA offers technical and legal assistance on all levels and in all areas relating to intellectual property rights, i.e. all issues relating to patents, trademarks, designs, copyrights, domain names, and m...

SU2C/Amgen

Atlantic Technology Ventures Incorproated

Atlantic Technology Ventures, Inc. (OTC: ATLC.OB), formerly known as Atlantic Pharmaceuticals, Inc., is a technology incubator engaged in developing and commercializing a diverse portfolio of patented technologies. The Company identifies nascent products and technologies that it believes have potential significant commercial viability and address unmet market needs. The Company funds research and ...

Omthera Pharmaceuticals, Inc.

Omthera Pharmaceuticals, Inc. is a specialty pharmaceuticals company with an experienced team of experts in drug development focusing its efforts on the clinical development of new therapies for dyslipidemia. The lead product candidate is Epanova™, an Omega-3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic ...

Coalition to Protect Patients’ Rights

The Coalition to Protect Patients’ Rights is a non-partisan, grassroots coalition made up of over 10,000 doctors, healthcare providers, advocacy groups, and concerned citizens who are dedicated to the implementation of patient-centered healthcare reform that will improve patient care. For more information, visit the Coalition to Protect Patients’...

Jericho Systems Corporation and Patient Privacy Rights

Patient Privacy Rights is the nation’s leading health privacy watchdog. Our mission is to ensure the right to control sensitive health information in electronic health systems, from prescription records to DNA, to protect jobs, reputations, and future opportunities. Patient Privacy Rights has over 12,000 members in all 50 states and leads the bipartis...

Isler & Pedrazzini AG

It is our goal to become your strategic partner through uniqueness and quality“In order to be successful in today’s economic environment, an enterprise must distinguish itself from its competitors – be unique – and must concentrate on its strengths. This is not only true for you as an entrepreneur, but also for us as counsellors.It is your strength to be ahead of your competitors by provid...

OctoPlus N.V.

OctoPlus is a drug product development company that is globally renowned as a center of excellence in formulation development, drug delivery and manufacturing. We offer proven and reliable services in formulation development, analytical development, process development and GMP manufacturing. Our expertise is focused on formulation of biotech-derived compounds and small chemical molecules. In...

Galenica AB

Galenica´s strategy is to enter as a highly qualified partner in all aspects of the development of new drugs. Galenica offers full coverage from traditional pharmaceutical formulation, formulation development, biopharmaceutical evaluation, GMP-manufacturing, quality control to regulatory elements of drug development.

Lux Biosciences, Inc.

Lux Biosciences, Inc. is a privately held biotechnology company focused on the treatment of ophthalmic diseases. Lux Biosciences has exclusive worldwide rights to voclosporin for all ophthalmic indications and is cooperating with the team at Isotechnika Pharma who discovered the molecule. For more information on Lux Biosciences, please visit the companyâ...

DisperSol Technologies LLC

DisperSol is an innovator in the formulation development and manufacture of pharmaceutical drugs. DisperSol’s KinetiSol® technology has dramatically improved the effectiveness of drugs by superior enhancement of drug loading, solubility, permeability and bioavailability relative to other technologies. This has enabled the improvement of approved dr...


More From BioPortfolio on "Amgen gets rights Captisol formulation technology BiTE"

Quick Search
Advertisement
 

Corporate Database Quicklinks